Minimally Invasive Surgery Market by Type (Surgical Device, Imaging System, Electrosurgical Device, Endoscopy Device, Medical Robotics), Application (Urological, Vascular, Oncological), End User (Hospital, Clinic, ASC) Region-Global Forecast to 2030

1 INTRODUCTION 34 1.1 STUDY OBJECTIVES 34 1.2 MARKET DEFINITION 34 1.3 STUDY SCOPE 35 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 35 1.3.2 INCLUSIONS & EXCLUSIONS 36 1.3.3 YEARS CONSIDERED 37 1.3.4 CURRENCY CONSIDERED 38 1.4 STAKEHOLDERS 38 1.5 SUMMARY OF CHANGES 39 2 RESEARCH METHODOLOGY 40 2.1 RESEARCH DATA 40 2.1.1 SECONDARY RESEARCH 40 2.1.1.1 Key objectives of secondary research 41 2.1.1.2 Key sources of secondary data 41 2.1.1.3 Key data from secondary sources 42 2.1.2 PRIMARY RESEARCH 42 2.1.2.1 Key primary sources 43 2.1.2.2 Key objectives of primary research 43 2.1.2.3 Key data from primary sources 44 2.1.2.4 Key industry insights 45 2.2 MARKET SIZE ESTIMATION 46 2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS) 46 2.2.2 TOP-DOWN APPROACH 47 2.2.3 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS 47 2.2.4 DEMAND-SIDE MODELLING 47 2.3 DATA TRIANGULATION 50 2.4 MARKET RANKING ANALYSIS 50 2.5 STUDY ASSUMPTIONS 51 2.6 RESEARCH LIMITATIONS 51 2.6.1 METHODOLOGY-RELATED LIMITATIONS 51 2.6.2 SCOPE-RELATED LIMITATIONS 51 2.7 RISK ANALYSIS 52 3 EXECUTIVE SUMMARY 53   4 PREMIUM INSIGHTS 57 4.1 MINIMALLY INVASIVE SURGERY MARKET OVERVIEW 57 4.2 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER AND COUNTRY 58 4.3 MINIMALLY INVASIVE SURGERY MARKET: GEOGRAPHIC SNAPSHOT 59 4.4 MINIMALLY INVASIVE SURGERY MARKET: REGIONAL MIX 59 4.5 MINIMALLY INVASIVE SURGERY MARKET: EMERGING VS. DEVELOPED MARKETS 60 5 MARKET OVERVIEW 61 5.1 INTRODUCTION 61 5.2 MARKET DYNAMICS 61 5.2.1 DRIVERS 62 5.2.1.1 Rising geriatric population and increasing number of surgeries 62 5.2.1.2 Growing adoption of minimally invasive surgeries over traditional open surgical procedures 62 5.2.1.3 Advantages of robot-assisted surgery and training in rehabilitation therapy 63 5.2.2 RESTRAINTS 63 5.2.2.1 High cost of robotic systems 63 5.2.3 OPPORTUNITIES 63 5.2.3.1 High growth opportunities in emerging markets 63 5.2.3.2 Increasing adoption of advanced robotics in ambulatory surgery centers 64 5.2.4 CHALLENGES 64 5.2.4.1 Changing regulatory landscape in medical device industry 64 5.3 TECHNOLOGY ANALYSIS 64 5.3.1 KEY TECHNOLOGIES 64 5.3.1.1 Laparoscopy 64 5.3.1.2 Electrosurgery 65 5.3.2 COMPLEMENTARY TECHNOLOGIES 65 5.3.2.1 Robotic surgery 65 5.3.2.2 Medical and surgical imaging 65 5.3.3 ADJACENT TECHNOLOGIES 65 5.3.3.1 Artificial intelligence and machine learning 65 5.4 INDUSTRY TRENDS 66 5.4.1 INTEGRATION OF ARTIFICAL INTELLIGENCE AND MACHINE LEARNING 66 5.4.2 TECHNOLOGICAL ADVANCEMENTS IN IMAGING 66 5.5 VALUE CHAIN ANALYSIS 66 5.6 ECOSYSTEM ANALYSIS 67 5.7 SUPPLY CHAIN ANALYSIS 68 5.8 TRADE ANALYSIS 69 5.8.1 IMPORT DATA FOR HS CODE 9018, 2019–2024 69 5.8.2 EXPORT SCENARIO FOR HS CODE 9018, 2019–2024 70 5.9 PORTER’S FIVE FORCES ANALYSIS 71 5.9.1 THREAT OF NEW ENTRANTS 72 5.9.2 THREAT OF SUBSTITUTES 72 5.9.3 BARGAINING POWER OF BUYERS 72 5.9.4 BARGAINING POWER OF SUPPLIERS 72 5.9.5 INTENSITY OF COMPETITIVE RIVALRY 73 5.10 KEY STAKEHOLDERS & BUYING CRITERIA 73 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 73 5.10.2 KEY BUYING CRITERIA 74 5.11 REGULATORY ANALYSIS 75 5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75 5.11.2 REGULATORY FRAMEWORK 77 5.11.2.1 North America 77 5.11.2.1.1 US 77 5.11.2.1.2 Canada 78 5.11.2.2 Europe 79 5.11.2.3 Asia Pacific 79 5.11.2.3.1 Japan 79 5.11.2.3.2 China 80 5.11.2.3.3 India 81 5.11.2.4 Latin America 81 5.11.2.5 Middle East & Africa 81 5.12 PATENT ANALYSIS 82 5.12.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 83 5.13 PRICING ANALYSIS 83 5.13.1 AVERAGE SELLING PRICE TREND OF MINIMALLY INVASIVE SURGICAL PRODUCTS, BY KEY PLAYER 83 5.13.2 AVERAGE SELLING PRICE TREND OF MINIMALLY INVASIVE SURGICAL PRODUCTS, BY REGION, 2022–2024 85 5.14 KEY CONFERENCES & EVENTS, 2025–2026 86 5.15 ADJACENT MARKET ANALYSIS 86 5.15.1 ENDOSCOPY EQUIPMENT MARKET 86 5.16 UNMET NEEDS/END-USER EXPECTATIONS 87 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 88 5.18 INVESTMENT & FUNDING SCENARIO 88 5.19 IMPACT OF AI/GEN AI ON MINIMALLY INVASIVE SURGERY MARKET 89 5.20 IMPACT OF 2025 US TARIFF ON MINIMALLY INVASIVE SURRGERY MARKET 90 5.20.1 INTRODUCTION 90 5.20.2 KEY TARIFF RATES 91 5.20.3 PRICE IMPACT ANALYSIS 92 5.20.4 KEY IMPACT ON COUNTRY/REGION 92 5.20.4.1 North America 92 5.20.4.1.1 US 92 5.20.4.2 Europe 93 5.20.4.3 Asia Pacific 93 5.20.5 IMPACT ON END-USE INDUSTRIES 93 6 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT 94 6.1 INTRODUCTION 95 6.2 SURGICAL DEVICES 96 6.2.1 HANDHELD INSTRUMENTS 98 6.2.1.1 Tubular retractors 99 6.2.1.1.1 Minimized tissue trauma and better outcomes to support adoption 99 6.2.1.2 Dilators 100 6.2.1.2.1 Increased focus on safety and efficient surgical site access to boost segment growth 100 6.2.1.3 Suturing instruments 101 6.2.1.3.1 Rising demand and procedural volume for minimally invasive surgeries to drive market 101 6.2.1.4 Probes 102 6.2.1.4.1 Advancements in instrumentation to fuel adoption in diagnostic purposes 102 6.2.1.5 Laser fiber devices 103 6.2.1.5.1 Laser fiber devices to focus on precise and controlled procedures with minimal tissue trauma 103 6.2.2 LAPAROSCOPY DEVICES 104 6.2.2.1 Laparoscopes 106 6.2.2.1.1 Lower surgical infection risk to drive demand 106 6.2.2.2 Trocars & cannulas 107 6.2.2.2.1 Need to ensure accurate placement of medications during surgeries to support segment growth 107 6.2.2.3 Graspers & dissectors 108 6.2.2.3.1 Increased safety and better precision to fuel market growth 108 6.2.3 INFLATION SYSTEMS 109 6.2.3.1 Balloon catheters 110 6.2.3.1.1 Increasing prevalence of cardiovascular diseases to boost market growth 110 6.2.3.2 Balloon inflation systems 111 6.2.3.2.1 Growing adoption of minimally invasive coronary and peripheral procedures to accelerate market growth 111 6.2.4 GUIDING DEVICES 112 6.2.4.1 Guiding catheters 113 6.2.4.1.1 Rising demand for precise navigation and device placement in complex minimally invasive surgeries to drive demand 113   6.2.4.2 Guidewires 114 6.2.4.2.1 Rising PCTA and PTA procedural volumes to ensure demand growth 114 6.3 IMAGING & VISUALIZATION SYSTEMS 115 6.3.1 ULTRASOUND SYSTEMS 116 6.3.1.1 Rising chronic disease burden to drive demand for reliable, non-invasive ultrasound imaging 116 6.3.1.2 CT scanners 118 6.3.1.2.1 Rising demand for high-resolution imaging in complex minimally invasive surgeries to support market growth 118 6.3.2 MRI SYSTEMS 119 6.3.2.1 Rising cancer prevalence to increase reliance on MRI for early detection and image-guided surgeries 119 6.3.3 X-RAY SYSTEMS 121 6.3.3.1 Rapid, low-cost digital imaging and high patient throughput to favor market growth 121 6.3.4 OTHER IMAGING & VISUALIZATION SYSTEMS 122 6.4 ELECTROSURGAL DEVICES 123 6.4.1 ELECTROCAUTERY DEVICES 124 6.4.1.1 High demand for precise cutting and coagulation to boost electrocautery device use in minimally invasive procedures 124 6.4.2 ELECTROSURGICAL GENERATORS & ACCESSORIES 125 6.4.2.1 Growing use of disposables and reusable instruments to propel segment growth 125 6.5 ENDOSCOPY DEVICES 126 6.5.1 RIGID ENDOSCOPES 128 6.5.1.1 Rising joint and urologic disorders to drive demand in high-volume minimally invasive surgeries 128 6.5.2 FLEXIBLE ENDOSCOPES 129 6.5.2.1 Increased preventive screening and early cancer detection to elevate flexible endoscope adoption 129 6.6 MEDICAL ROBOTICS 130 6.6.1 ROBOTIC SYSTEMS 131 6.6.1.1 Superior precision, enhanced control, and ability to perform complex procedures with greater dexterity to drive market 131 6.6.2 ROBOTIC INSTRUMENTS 132 6.6.2.1 Growing volume of robotic surgical procedures to augment market growth 132 6.6.3 ROBOTIC SOFTWARE & SERVICES 133 6.6.3.1 Rising robotic installations to increase demand for bundled training, maintenance, and technical support services 133   7 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION 135 7.1 INTRODUCTION 136 7.2 GASTROINTESTINAL & ABDOMINAL SURGERY 137 7.2.1 RISING GLOBAL BURDEN OF GASTROINTESTINAL CANCERS AND DIGESTIVE DISORDERS TO DRIVE MARKET 137 7.3 CARDIOTHORACIC SURGERY 138 7.3.1 INCREASING CARDIOVASCULAR AND THORACIC CONDITIONS TO INCREASE PRECISION-BASED MINIMALLY INVASIVE PROCEDURES 138 7.4 ORTHOPEDIC SURGERY 139 7.4.1 RISING BURDEN OF MUSCULOSKELETAL DISORDERS AND GROWING GERIATRIC POPULATION TO AID MARKET GROWTH 139 7.5 VASCULAR SURGERY 140 7.5.1 MINIMALLY INVASIVE VASCULAR SURGERY PRODUCTS TO REPLACE CONVENTIONAL SUTURE-BASED METHODS 140 7.6 GYNECOLOGICAL SURGERY 141 7.6.1 HIGH INCIDENCE OF GYNECOLOGICAL DISORDERS TO FUEL SEGMENT GROWTH 141 7.7 ONCOLOGICAL SURGERY 142 7.7.1 HIGH CANCER INCIDENCE AND ADOPTION OF ADVANCED PRECISION SURGICAL TECHNOLOGIES TO BOOST MARKET GROWTH 142 7.8 NEUROLOGICAL SURGERY 143 7.8.1 INCREASING GERIATRIC POPULATION AND RISING OCCURRENCE OF NEURODEGENERATIVE DISORDERS TO PROPEL MARKET GROWTH 143 7.9 UROLOGICAL SURGERY 144 7.9.1 INCREASING PREVALENCE OF UROLOGICAL CANCERS TO AUGMENT MARKET GROWTH 144 7.10 ENT & RESPIRATORY SURGERY 145 7.10.1 GROWING GLOBAL BURDEN OF COPD AND HEAD & NECK CANCERS TO DRIVE MARKET 145 7.11 COSMETIC SURGERY 146 7.11.1 HIGH DEMAND FOR AESTHETIC ENHANCEMENT WITH MINIMAL DOWNTIME TO PROPEL MARKET GROWTH 146 7.12 DENTAL SURGERY 147 7.12.1 RISING PATIENT DEMAND FOR LESS PAINFUL AND TISSUE-PRESERVING TREATMENTS TO FAVOR MARKET GROWTH 147 7.13 OTHER SURGERIES 148 8 MINIMALLY INVASIVE SURGERY MARKET, BY END USER 149 8.1 INTRODUCTION 150 8.2 HOSPITALS 150 8.2.1 RISING CHRONIC DISEASE BURDEN TO DRIVE PATIENT PREFERENCE FOR ADVANCED MINIMALLY INVASIVE SURGERIES IN HOSPITALS 150 8.3 AMBULATORY SURGERY CENTERS 151 8.3.1 GROWING PATIENT PREFERENCE FOR QUICKER DISCHARGE AND LOWER COSTS TO BOOST MARKET GROWTH 151 8.4 CLINICS 153 8.4.1 PREFERENCE FOR OUTPATIENT AND COST-EFFECTIVE MINIMALLY INVASIVE SURGICAL PROCEDURES TO AID MARKET GROWTH 153 8.5 EMERGENCY & TRAUMA CENTERS 154 8.5.1 INCREASING DEMAND FOR SAME-DAY SURGERIES TO AUGMENT MARKET GROWTH 154 8.6 OTHER END USERS 155 9 MINIMALLY INVASIVE SURGERY MARKET, BY REGION 156 9.1 INTRODUCTION 157 9.2 NORTH AMERICA 159 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 159 9.2.2 US 166 9.2.2.1 US to dominate North American minimally invasive surgery market during forecast period 166 9.2.3 CANADA 171 9.2.3.1 High geriatric population with chronic diseases to propel market growth 171 9.3 EUROPE 176 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 176 9.3.2 GERMANY 184 9.3.2.1 Increased cancer incidence and strong healthcare infrastructure to fuel market growth 184 9.3.3 UK 189 9.3.3.1 Increasing geriatric population and rising need for oncological surgeries to stimulate market growth 189 9.3.4 FRANCE 194 9.3.4.1 High burden of non-communicable diseases to accelerate demand for minimally invasive procedures 194 9.3.5 ITALY 199 9.3.5.1 Increasing geriatric population to support adoption of minimally invasive procedures in degenerative conditions 199 9.3.6 SPAIN 204 9.3.6.1 Robust public healthcare and focus on reduced post-operative complications to augment market growth 204 9.3.7 REST OF EUROPE 209 9.4 ASIA PACIFIC 214 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 214 9.4.2 CHINA 220 9.4.2.1 Growing need for less invasive and high-precision surgical interventions to drive market 220 9.4.3 INDIA 225 9.4.3.1 Need for cost-effective and efficient surgical options in resource-constrained healthcare system to drive adoption 225   9.4.4 JAPAN 230 9.4.4.1 Advanced medical technology adoption and strong focus on patient-centric care to accelerate market growth 230 9.4.5 SOUTH KOREA 235 9.4.5.1 High demand for plastic surgeries and adoption of advanced robotics to aid market growth 235 9.4.6 AUSTRALIA 240 9.4.6.1 Increasing chronic disease burden and booming cosmetic surgery rates to fuel market expansion 240 9.4.7 REST OF ASIA PACIFIC 245 9.5 LATIN AMERICA 250 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 250 9.5.2 BRAZIL 256 9.5.2.1 Substantial public health investment and advanced dual public-private healthcare system to favor market growth 256 9.5.3 MEXICO 261 9.5.3.1 Rising obesity across age groups to fuel demand for minimally invasive surgical procedures in Mexican healthcare system 261 9.5.4 REST OF LATIN AMERICA 266 9.6 MIDDLE EAST & AFRICA 271 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 271 9.6.2 GCC COUNTRIES 277 9.6.2.1 Increased government healthcare investments and adoption of advanced medical technologies to spur market growth 277 9.6.3 REST OF MIDDLE EAST & AFRICA 283 10 COMPETITIVE LANDSCAPE 288 10.1 INTRODUCTION 288 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 288 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MINIMALLY INVASIVE SURGERY MARKET 288 10.3 REVENUE ANALYSIS, 2020–2024 289 10.4 MARKET SHARE ANALYSIS, 2024 290 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 293 10.5.1 STARS 293 10.5.2 EMERGING LEADERS 293 10.5.3 PERVASIVE PLAYERS 293 10.5.4 PARTICIPANTS 293 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 295 10.5.5.1 Company footprint 295 10.5.5.2 Region footprint 296 10.5.5.3 Product footprint 297 10.5.5.4 Application footprint 298 10.5.5.5 End-user footprint 299 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 300 10.6.1 PROGRESSIVE COMPANIES 300 10.6.2 RESPONSIVE COMPANIES 300 10.6.3 DYNAMIC COMPANIES 300 10.6.4 STARTING BLOCKS 301 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 302 10.6.5.1 Detailed list of key startups/SMEs 302 10.6.5.2 Competitive benchmarking of key startups/SMEs 302 10.7 COMPANY VALUATION & FINANCIAL METRICS 303 10.7.1 FINANCIAL METRICS 303 10.7.2 COMPANY VALUATION 303 10.8 BRAND/PRODUCT COMPARISON 304 10.9 COMPETITIVE SCENARIO 305 10.9.1 PRODUCT LAUNCHES AND APPROVALS 305 10.9.2 DEALS 306 11 COMPANY PROFILES 307 11.1 KEY PLAYERS 307 11.1.1 MEDTRONIC 307 11.1.1.1 Business overview 307 11.1.1.2 Products offered 308 11.1.1.3 Recent developments 313 11.1.1.3.1 Product approvals 313 11.1.1.3.2 Expansions 313 11.1.1.4 MnM view 313 11.1.1.4.1 Right to win 313 11.1.1.4.2 Strategic choices 313 11.1.1.4.3 Weaknesses & competitive threats 314 11.1.2 JOHNSON & JOHNSON 315 11.1.2.1 Business overview 315 11.1.2.2 Products offered 316 11.1.2.3 Recent developments 318 11.1.2.3.1 Product approvals 318 11.1.2.3.2 Deals 318 11.1.2.4 MnM view 319 11.1.2.4.1 Right to win 319 11.1.2.4.2 Strategic choices 319 11.1.2.4.3 Weaknesses & competitive threats 319 11.1.3 STRYKER 320 11.1.3.1 Business overview 320 11.1.3.2 Products offered 321 11.1.3.3 Recent developments 323 11.1.3.3.1 Product launches and approvals 323 11.1.3.3.2 Deals 324 11.1.3.4 MnM view 324 11.1.3.4.1 Right to win 324 11.1.3.4.2 Strategic choices 324 11.1.3.4.3 Weaknesses & competitive threats 324 11.1.4 BOSTON SCIENTIFIC CORPORATION 325 11.1.4.1 Business overview 325 11.1.4.2 Products offered 326 11.1.4.3 Recent developments 327 11.1.4.3.1 Deals 327 11.1.4.4 MnM view 328 11.1.4.4.1 Right to win 328 11.1.4.4.2 Strategic choices 329 11.1.4.4.3 Weaknesses & competitive threats 329 11.1.5 ABBOTT 330 11.1.5.1 Business overview 330 11.1.5.2 Products offered 331 11.1.5.3 Recent developments 332 11.1.5.3.1 Deals 332 11.1.5.4 MnM view 332 11.1.5.4.1 Right to win 332 11.1.5.4.2 Strategic choices 332 11.1.5.4.3 Weaknesses & competitive threats 332 11.1.6 ZIMMER BIOMET 333 11.1.6.1 Business overview 333 11.1.6.2 Products offered 334 11.1.6.3 Recent developments 335 11.1.6.3.1 Product approvals 335 11.1.6.3.2 Deals 335 11.1.7 B. BRAUN SE 336 11.1.7.1 Business overview 336 11.1.7.2 Products offered 337 11.1.8 GLOBUS MEDICAL 339 11.1.8.1 Business overview 339 11.1.8.2 Products offered 340 11.1.8.3 Recent developments 341 11.1.8.3.1 Deals 341 11.1.9 INTEGRA LIFESCIENCES CORPORATION 342 11.1.9.1 Business overview 342 11.1.9.2 Products offered 343   11.1.10 SIEMENS HEALTHINEERS AG 344 11.1.10.1 Business overview 344 11.1.10.2 Products offered 345 11.1.10.3 Recent developments 347 11.1.10.3.1 Product launches 347 11.1.10.3.2 Expansions 348 11.1.11 FUJIFILM CORPORATION 349 11.1.11.1 Business overview 349 11.1.11.2 Products offered 350 11.1.11.3 Recent developments 352 11.1.11.3.1 Product launches and approvals 352 11.1.11.3.2 Deals 352 11.1.12 KONINKLIJKE PHILIPS N.V. 353 11.1.12.1 Business overview 353 11.1.12.2 Products offered 354 11.1.12.3 Recent developments 356 11.1.12.3.1 Product launches and approvals 356 11.1.12.3.2 Deals 357 11.1.13 INTUITIVE SURGICAL OPERATIONS, INC. 358 11.1.13.1 Business overview 358 11.1.13.2 Products offered 359 11.1.13.3 Recent developments 360 11.1.13.3.1 Product approvals 360 11.1.14 KARL STORZ SE & CO. KG 361 11.1.14.1 Business overview 361 11.1.14.2 Products offered 361 11.1.14.3 Recent developments 363 11.1.14.3.1 Deals 363 11.1.14.3.2 Expansions 363 11.1.15 GE HEALTHCARE 364 11.1.15.1 Business overview 364 11.1.15.2 Products offered 365 11.1.15.3 Recent developments 367 11.1.15.3.1 Product launches 367 11.1.15.3.2 Deals 367 11.2 OTHER PLAYERS 368 11.2.1 NIPRO 368 11.2.2 SMITH+NEPHEW 369 11.2.3 GETINGE 370 11.2.4 CONMED CORPORATION 371 11.2.5 TELEFLEX INCORPORATED 372 11.2.6 OLYMPUS CORPORATION 373 11.2.7 COOPERSURGICAL, INC. 374 11.2.8 APPLIED MEDICAL RESOURCES CORPORATION 375 11.2.9 OTU MEDICAL 376 11.2.10 ATMOS MEDIZINTECHNIK GMBH & CO. KG 377 12 APPENDIX 378 12.1 DISCUSSION GUIDE 378 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 386 12.3 CUSTOMIZATION OPTIONS 388 12.4 RELATED REPORTS 388 12.5 AUTHOR DETAILS 389

TABLE 1 MINIMALLY INVASIVE SURGERY MARKET: INCLUSIONS & EXCLUSIONS 36 TABLE 2 STANDARD CURRENCY CONVERSION RATES 38 TABLE 3 MINIMALLY INVASIVE SURGERY MARKET: STUDY ASSUMPTIONS 51 TABLE 4 MINIMALLY INVASIVE SURGERY MARKET: RISK ANALYSIS 52 TABLE 5 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2019–2024 (USD THOUSAND) 70 TABLE 6 EXPORT DATA FOR HS CODE 9018, BY COUNTRY, 2019–2024 (USD THOUSAND) 70 TABLE 7 MINIMALLY INVASIVE SURGERY MARKET: PORTER’S FIVE FORCES 71 TABLE 8 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR MINIMALLY INVASIVE SURGICAL PRODUCTS 74 TABLE 9 KEY BUYING CRITERIA FOR MAJOR MINIMALLY INVASIVE SURGICAL PRODUCTS 75 TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75 TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 14 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 15 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 78 TABLE 16 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 78 TABLE 17 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 79 TABLE 18 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES IN JAPAN 80 TABLE 19 NMPA MEDICAL DEVICES CLASSIFICATION 81 TABLE 20 AVERAGE SELLING PRICE TREND OF MINIMALLY INVASIVE SURGICAL PRODUCTS, BY KEY PLAYER, 2022–2024 (USD) 84 TABLE 21 AVERAGE SELLING PRICE TREND OF MINIMALLY INVASIVE SURGICAL PRODUCTS, BY REGION, 2022–2024 (USD) 85 TABLE 22 MINIMALLY INVASIVE SURGERY MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026 86 TABLE 23 MINIMALLY INVASIVE SURGERY MARKET: UNMET NEEDS/END-USER EXPECTATIONS 87 TABLE 24 US-ADJUSTED RECIPROCAL TARIFF RATES 91 TABLE 25 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR ORTHODONTIC SUPPLIES 92 TABLE 26 MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 95 TABLE 27 MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 96 TABLE 28 MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 97 TABLE 29 HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 98 TABLE 30 HANDHELD INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99 TABLE 31 TUBULAR RETRACTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 100 TABLE 32 DILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 101 TABLE 33 SUTURING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 34 PROBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 35 LASER FIBER DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 36 LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 105 TABLE 37 LAPAROSCOPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 38 LAPAROSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 39 TROCARS & CANNULAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 40 GRASPERS & DISSECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 41 INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 109 TABLE 42 INFLATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 43 BALLOON CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 44 BALLON INFLATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 45 GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 112 TABLE 46 GUIDING DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 47 GUIDING CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 48 GUIDEWIRES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 49 MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 115 TABLE 50 MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 51 ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 52 CT SCANNERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 53 MRI SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 54 X-RAY SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 55 OTHER IMAGING & VISUALIZATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 56 MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 123 TABLE 57 MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 58 ELECTROCAUTERY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 59 ELECTROSURGICAL GENERATORS & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 60 MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 127 TABLE 61 MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 62 RIGID ENDOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 63 FLEXIBLE ENDOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 64 MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 130 TABLE 65 MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 66 ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 67 ROBOTIC INTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 68 ROBOTIC SOFTWARE & SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 69 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 136 TABLE 70 MINIMALLY INVASIVE GASTROINTESTINAL & ABDOMINAL SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 71 MINIMALLY INVASIVE CARDIOTHORACIC SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 72 MINIMALLY INVASIVE ORTHOPEDIC SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 73 MINIMALLY INVASIVE VASCULAR SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 74 MINIMALLY INVASIVE GYNECOLOGICAL SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 75 MINIMALLY INVASIVE ONCOLOGICAL SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 76 MINIMALLY INVASIVE NEUROLOGICAL SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 77 MINIMALLY INVASIVE UROLOGICAL SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 78 MINIMALLY INVASIVE ENT & RESPIRATORY SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 79 MINIMALLY INVASIVE COSMETIC SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 80 MINIMALLY INVASIVE DENTAL SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 81 MINIMALLY INVASIVE OTHER SURGERIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 82 MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 150 TABLE 83 MINIMALLY INVASIVE SURGERY MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 84 MINIMALLY INVASIVE SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 85 MINIMALLY INVASIVE SURGERY MARKET FOR CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 86 MINIMALLY INVASIVE SURGERY MARKET FOR EMERGENCY & TRAUMA CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 87 MINIMALLY INVASIVE SURGERY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 88 MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2023–2030 (USD MILLION) 158 TABLE 89 MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 158 TABLE 90 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 91 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY TYPE, 2023–2030 (THOUSAND UNITS) 161 TABLE 92 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 161 TABLE 93 NORTH AMERICA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 94 NORTH AMERICA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 95 NORTH AMERICA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 96 NORTH AMERICA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 163 TABLE 97 NORTH AMERICA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 163 TABLE 98 NORTH AMERICA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 163 TABLE 99 NORTH AMERICA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 164 TABLE 100 NORTH AMERICA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 164 TABLE 101 NORTH AMERICA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 164 TABLE 102 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 165 TABLE 103 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 165 TABLE 104 US: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 166 TABLE 105 US: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 167 TABLE 106 US: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 167 TABLE 107 US: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 167 TABLE 108 US: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 109 US: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 110 US: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 111 US: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 112 US: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 113 US: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 114 US: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 170 TABLE 115 US: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 170 TABLE 116 CANADA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 171 TABLE 117 CANADA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 118 CANADA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 119 CANADA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 120 CANADA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 121 CANADA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 122 CANADA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 123 CANADA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 124 CANADA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 125 CANADA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 126 CANADA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 175 TABLE 127 CANADA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 175 TABLE 128 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 129 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 178 TABLE 130 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 179 TABLE 131 EUROPE: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 179 TABLE 132 EUROPE: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 133 EUROPE: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 134 EUROPE: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 135 EUROPE: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 136 EUROPE: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 137 EUROPE: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 138 EUROPE: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 182 TABLE 139 EUROPE: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 182 TABLE 140 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 183 TABLE 141 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 183 TABLE 142 GERMANY: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 184 TABLE 143 GERMANY: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 144 GERMANY: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 145 GERMANY: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 146 GERMANY: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 147 GERMANY: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 148 GERMANY: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 149 GERMANY: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 150 GERMANY: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 151 GERMANY: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 152 GERMANY: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 188 TABLE 153 GERMANY: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 188 TABLE 154 UK: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 189 TABLE 155 UK: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 156 UK: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 157 UK: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 158 UK: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 159 UK: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 160 UK: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 161 UK: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 162 UK: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 163 UK: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 164 UK: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 193 TABLE 165 UK: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 193 TABLE 166 FRANCE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 194 TABLE 167 FRANCE: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 168 FRANCE: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 169 FRANCE: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 170 FRANCE: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 171 FRANCE: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 172 FRANCE: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 173 FRANCE: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 174 FRANCE: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 175 FRANCE: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 176 FRANCE: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 198 TABLE 177 FRANCE: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 198 TABLE 178 ITALY: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 199 TABLE 179 ITALY: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 199 TABLE 180 ITALY: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 181 ITALY: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 182 ITALY: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 183 ITALY: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 184 ITALY: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 185 ITALY: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 186 ITALY: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 187 ITALY: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 188 ITALY: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 203 TABLE 189 ITALY: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 203 TABLE 190 SPAIN: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 204 TABLE 191 SPAIN: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 192 SPAIN: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 193 SPAIN: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 194 SPAIN: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 195 SPAIN: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 196 SPAIN: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 197 SPAIN: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 198 SPAIN: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 199 SPAIN: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 200 SPAIN: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 208 TABLE 201 SPAIN: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 208 TABLE 202 REST OF EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 209 TABLE 203 REST OF EUROPE: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 209 TABLE 204 REST OF EUROPE: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 205 REST OF EUROPE: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 206 REST OF EUROPE: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 207 REST OF EUROPE: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 208 REST OF EUROPE: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 209 REST OF EUROPE: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 210 REST OF EUROPE: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 211 REST OF EUROPE: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 212 REST OF EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 213 TABLE 213 REST OF EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 213 TABLE 214 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 215 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (THOUSAND UNITS) 215 TABLE 216 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 215 TABLE 217 ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 218 ASIA PACIFIC: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 219 ASIA PACIFIC: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 220 ASIA PACIFIC: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 221 ASIA PACIFIC: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 222 ASIA PACIFIC: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 223 ASIA PACIFIC: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 224 ASIA PACIFIC: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 225 ASIA PACIFIC: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 226 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 219 TABLE 227 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 219 TABLE 228 CHINA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 220 TABLE 229 CHINA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 230 CHINA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 231 CHINA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 232 CHINA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 233 CHINA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 234 CHINA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 235 CHINA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 236 CHINA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 237 CHINA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 238 CHINA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 224 TABLE 239 CHINA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 224 TABLE 240 INDIA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 225 TABLE 241 INDIA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 242 INDIA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 243 INDIA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 244 INDIA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 245 INDIA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 246 INDIA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 247 INDIA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 248 INDIA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 249 INDIA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 250 INDIA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 229 TABLE 251 INDIA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 229 TABLE 252 JAPAN: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 230 TABLE 253 JAPAN: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 230 TABLE 254 JAPAN: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 255 JAPAN: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 256 JAPAN: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 257 JAPAN: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 258 JAPAN: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 259 JAPAN: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 260 JAPAN: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 261 JAPAN: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 262 JAPAN: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 234 TABLE 263 JAPAN: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 234 TABLE 264 SOUTH KOREA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 235 TABLE 265 SOUTH KOREA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 266 SOUTH KOREA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 267 SOUTH KOREA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 268 SOUTH KOREA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 269 SOUTH KOREA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 270 SOUTH KOREA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 271 SOUTH KOREA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 272 SOUTH KOREA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 273 SOUTH KOREA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 274 SOUTH KOREA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 239 TABLE 275 SOUTH KOREA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 239 TABLE 276 AUSTRALIA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 240 TABLE 277 AUSTRALIA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 278 AUSTRALIA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 279 AUSTRALIA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 280 AUSTRALIA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 281 AUSTRALIA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 282 AUSTRALIA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 283 AUSTRALIA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 284 AUSTRALIA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 285 AUSTRALIA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 286 AUSTRALIA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 244 TABLE 287 AUSTRALIA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 244 TABLE 288 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 245 TABLE 289 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 245 TABLE 290 REST OF ASIA PACIFIC: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 291 REST OF ASIA PACIFIC: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 292 REST OF ASIA PACIFIC: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 293 REST OF ASIA PACIFIC: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 294 REST OF ASIA PACIFIC: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 295 REST OF ASIA PACIFIC: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 296 REST OF ASIA PACIFIC: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 297 REST OF ASIA PACIFIC: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 298 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 249 TABLE 299 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 249 TABLE 300 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 250 TABLE 301 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (THOUSAND UNITS) 251 TABLE 302 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 251 TABLE 303 LATIN AMERICA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 304 LATIN AMERICA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 305 LATIN AMERICA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 306 LATIN AMERICA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 307 LATIN AMERICA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 308 LATIN AMERICA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 309 LATIN AMERICA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 310 LATIN AMERICA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 311 LATIN AMERICA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 312 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 255 TABLE 313 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 256 TABLE 314 BRAZIL: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 256 TABLE 315 BRAZIL: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 316 BRAZIL: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 317 BRAZIL: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 318 BRAZIL: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 319 BRAZIL: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 320 BRAZIL: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 321 BRAZIL: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 322 BRAZIL: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 323 BRAZIL: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 324 BRAZIL: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 260 TABLE 325 BRAZIL: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 260 TABLE 326 MEXICO: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 261 TABLE 327 MEXICO: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 328 MEXICO: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 329 MEXICO: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 330 MEXICO: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 331 MEXICO: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 332 MEXICO: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 333 MEXICO: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 334 MEXICO: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 335 MEXICO: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 336 MEXICO: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 265 TABLE 337 MEXICO: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 265 TABLE 338 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 266 TABLE 339 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 340 REST OF LATIN AMERICA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 341 REST OF LATIN AMERICA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 342 REST OF LATIN AMERICA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 343 REST OF LATIN AMERICA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 344 REST OF LATIN AMERICA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 345 REST OF LATIN AMERICA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 346 REST OF LATIN AMERICA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 347 REST OF LATIN AMERICA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 348 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 270 TABLE 349 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 270 TABLE 350 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 271 TABLE 351 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 272 TABLE 352 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 272 TABLE 353 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 354 MIDDLE EAST & AFRICA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 355 MIDDLE EAST & AFRICA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 274 TABLE 356 MIDDLE EAST & AFRICA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 274 TABLE 357 MIDDLE EAST & AFRICA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 274 TABLE 358 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 359 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 360 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 361 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 276 TABLE 362 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 276 TABLE 363 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 277 TABLE 364 GCC COUNTRIES: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 278 TABLE 365 GCC COUNTRIES: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 366 GCC COUNTRIES: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 367 GCC COUNTRIES: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 368 GCC COUNTRIES: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 369 GCC COUNTRIES: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 370 GCC COUNTRIES: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 371 GCC COUNTRIES: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 372 GCC COUNTRIES: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 373 GCC COUNTRIES: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 374 GCC COUNTRIES: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 282 TABLE 375 GCC COUNTRIES: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 282 TABLE 376 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 283 TABLE 377 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 378 REST OF MIDDLE EAST & AFRICA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 379 REST OF MIDDLE EAST & AFRICA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 380 REST OF MIDDLE EAST & AFRICA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 381 REST OF MIDDLE EAST & AFRICA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 382 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 383 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 384 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 385 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 386 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 287 TABLE 387 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 287 TABLE 388 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN MINIMALLY INVASIVE SURGERY MARKET 288 TABLE 389 MINIMALLY INVASIVE SURGERY MARKET: DEGREE OF COMPETITION 291 TABLE 390 MINIMALLY INVASIVE SURGERY MARKET: REGION FOOTPRINT 296 TABLE 391 MINIMALLY INVASIVE SURGERY MARKET: PRODUCT FOOTPRINT 297 TABLE 392 MINIMALLY INVASIVE SURGERY MARKET: APPLICATION FOOTPRINT 298 TABLE 393 MINIMALLY INVASIVE SURGERY MARKET: END-USER FOOTPRINT 299 TABLE 394 MINIMALLY INVASIVE SURGERY MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 302 TABLE 395 MINIMALLY INVASIVE SURGERY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY PRODUCT AND REGION 302 TABLE 396 MINIMALLY INVASIVE SURGERY MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025 305 TABLE 397 MINIMALLY INVASIVE SURGERY MARKET: DEALS, JANUARY 2022–JULY 2025 306 TABLE 398 MEDTRONIC: COMPANY OVERVIEW 307 TABLE 399 MEDTRONIC: PRODUCTS OFFERED 308 TABLE 400 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2022–JULY 2025 313 TABLE 401 MEDTRONIC: EXPANSIONS, JANUARY 2022–JULY 2025 313 TABLE 402 JOHNSON & JOHNSON: COMPANY OVERVIEW 315 TABLE 403 JOHNSON & JOHNSON: PRODUCTS OFFERED 316 TABLE 404 JOHNSON & JOHNSON: PRODUCT APPROVALS, JANUARY 2022–JULY 2025 318 TABLE 405 JOHNSON & JOHNSON: DEALS, JANUARY 2022–JULY 2025 318 TABLE 406 STRYKER: COMPANY OVERVIEW 320 TABLE 407 STRYKER: PRODUCTS OFFERED 321 TABLE 408 STRYKER: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025 323 TABLE 409 STRYKER: DEALS, JANUARY 2022–JULY 2025 324 TABLE 410 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 325 TABLE 411 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 326 TABLE 412 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022–JULY 2025 327 TABLE 413 ABBOTT: COMPANY OVERVIEW 330 TABLE 414 ABBOTT: PRODUCTS OFFERED 331 TABLE 415 ABBOTT: DEALS, JANUARY 2022–JULY 2025 332 TABLE 416 ZIMMER BIOMET: COMPANY OVERVIEW 333 TABLE 417 ZIMMER BIOMET: PRODUCTS OFFERED 334 TABLE 418 ZIMMER BIOMET: PRODUCT APPROVALS, JANUARY 2022–JULY 2025 335 TABLE 419 ZIMMER BIOMET: DEALS, JANUARY 2022–JULY 2025 335 TABLE 420 B. BRAUN SE: COMPANY OVERVIEW 336 TABLE 421 B BRAUN SE: PRODUCTS OFFERED 337 TABLE 422 GLOBUS MEDICAL: COMPANY OVERVIEW 339 TABLE 423 GLOBUS MEDICAL: PRODUCTS OFFERED 340 TABLE 424 GLOBUS MEDICAL: DEALS, JANUARY 2022–JULY 2025 341 TABLE 425 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW 342 TABLE 426 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED 343 TABLE 427 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 344 TABLE 428 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 345 TABLE 429 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 347 TABLE 430 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2022–JULY 2025 348 TABLE 431 FUJIFILM CORPORATION: COMPANY OVERVIEW 349 TABLE 432 FUJIFILM CORPORATION: PRODUCTS OFFERED 350 TABLE 433 FUJIFILM CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025 352 TABLE 434 FUJIFILM CORPORATION: DEALS, JANUARY 2022–JULY 2025 352 TABLE 435 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 353 TABLE 436 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 354 TABLE 437 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025 356 TABLE 438 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–JULY 2025 357 TABLE 439 INTUITIVE SURGICAL OPERATIONS, INC.: COMPANY OVERVIEW 358 TABLE 440 INTUITIVE SURGICAL OPERATIONS, INC.: PRODUCTS OFFERED 359 TABLE 441 INTUITIVE SURGICAL OPERATIONS, INC.: PRODUCT APPROVALS, JANUARY 2022–JULY 2025 360 TABLE 442 KARL STORZ SE & CO. KG: COMPANY OVERVIEW 361 TABLE 443 KARL STORZ SE & CO. KG: PRODUCTS OFFERED 361 TABLE 444 KARL STORZ SE & CO. KG: DEALS, JANUARY 2022–JULY 2025 363 TABLE 445 KARL STORZ SE & CO. KG: EXPANSIONS, JANUARY 2022–JULY 2025 363 TABLE 446 GE HEALTHCARE: COMPANY OVERVIEW 364 TABLE 447 GE HEALTHCARE: PRODUCTS OFFERED 365 TABLE 448 GE HEALTHCARE: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 367 TABLE 449 GE HEALTHCARE: DEALS, JANUARY 2022–JULY 2025 367 TABLE 450 NIPRO: COMPANY OVERVIEW 368 TABLE 451 SMITH+NEPHEW: COMPANY OVERVIEW 369 TABLE 452 GETINGE: COMPANY OVERVIEW 370 TABLE 453 CONMED CORPORATION: COMPANY OVERVIEW 371 TABLE 454 TELEFLEX INCORPORATED: COMPANY OVERVIEW 372 TABLE 455 OLYMPUS CORPORATION: COMPANY OVERVIEW 373 TABLE 456 COOPERSURGICAL, INC.: COMPANY OVERVIEW 374 TABLE 457 APPLIED MEDICAL RESOURCES CORPORATION: COMPANY OVERVIEW 375 TABLE 458 OTU MEDICAL: COMPANY OVERVIEW 376 TABLE 459 ATMOS MEDIZINTECHNIK GMBH & CO. KG: COMPANY OVERVIEW 377 FIGURE 1 MINIMALLY INVASIVE SURGERY MARKET SEGMENTATION & REGIONAL SCOPE 35 FIGURE 2 MINIMALLY INVASIVE SURGERY MARKET: YEARS CONSIDERED 37 FIGURE 3 MINIMALLY INVASIVE SURGERY MARKET: RESEARCH DESIGN 40 FIGURE 4 MINIMALLY INVASIVE SURGERY MARKET: KEY DATA FROM SECONDARY SOURCES 42 FIGURE 5 MINIMALLY INVASIVE SURGERY MARKET: KEY PRIMARY SOURCES 43 FIGURE 6 MINIMALLY INVASIVE SURGERY MARKET: KEY DATA FROM PRIMARY SOURCES 44 FIGURE 7 MINIMALLY INVASIVE SURGERY MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS 45 FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 45 FIGURE 9 MINIMALLY INVASIVE SURGERY MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 46 FIGURE 10 MINIMALLY INVASIVE SURGERY MARKET: TOP-DOWN APPROACH 47 FIGURE 11 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MINIMALLY INVASIVE SURGERY MARKET (2025–2030) 48 FIGURE 12 MINIMALLY INVASIVE SURGERY MARKET: CAGR PROJECTIONS 49 FIGURE 13 MINIMALLY INVASIVE SURGERY MARKET: DATA TRIANGULATION METHODOLOGY 50 FIGURE 14 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 53 FIGURE 15 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 54 FIGURE 16 MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 55 FIGURE 17 MINIMALLY INVASIVE SURGERY MARKET: REGIONAL SNAPSHOT 56 FIGURE 18 HIGH VOLUME OF SURGICAL PROCEDURES AND PREFERENCE FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO DRIVE MARKET 57 FIGURE 19 US AND HOSPITALS SEGMENT COMMANDED LARGEST MARKET SHARE IN 2024 58 FIGURE 20 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 59 FIGURE 21 NORTH AMERICA TO GROW AT HIGHEST GROWTH RATE FROM 2025 TO 2030 59 FIGURE 22 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD 60 FIGURE 23 MINIMALLY INVASIVE SURGERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 61 FIGURE 24 MINIMALLY INVASIVE SURGERY MARKET: VALUE CHAIN ANALYSIS 67 FIGURE 25 MINIMALLY INVASIVE SURGERY MARKET: ECOSYSTEM ANALYSIS 68 FIGURE 26 MINIMALLY INVASIVE SURGERY MARKET: SUPPLY CHAIN ANALYSIS 69 FIGURE 27 MINIMALLY INVASIVE SURGERY MARKET: PORTER’S FIVE FORCES ANALYSIS 71 FIGURE 28 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR MINIMALLY INVASIVE SURGICAL PRODUCTS 73 FIGURE 29 KEY BUYING CRITERIA FOR MAJOR MINIMALLY INVASIVE SURGICAL PRODUCTS 74 FIGURE 30 TOP 10 COMPANIES WITH HIGHEST PATENT OWNERSHIPS/APPLICATIONS AND NUMBER OF PATENTS GRANTED (JANUARY 2015–JULY 2025) 82 FIGURE 31 TOP APPLICANT COUNTRIES/REGIONS FOR MINIMALLY INVASIVE SURGERY PATENTS (JANUARY 2014−MAY 2025) 83 FIGURE 32 ENDOSCOPY EQUIPMENT MARKET OVERVIEW 87 FIGURE 33 MINIMALLY INVASIVE SURGERY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 88 FIGURE 34 MINIMALLY INVASIVE SURGERY MARKET: FUNDING AND NUMBER OF DEALS (2019–2023) 89 FIGURE 35 IMPACT OF AI/GEN AI ON MINIMALLY INVASIVE SURGERY MARKET 90 FIGURE 36 MINIMALLY INVASIVE SURGERY MARKET: GEOGRAPHIC SNAPSHOT 157 FIGURE 37 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET SNAPSHOT 160 FIGURE 38 EUROPE: MINIMALLY INVASIVE SURGERY MARKET SNAPSHOT 177 FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN MINIMALLY INVASIVE SURGERY MARKET (2022–2024) 290 FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MINIMALLY INVASIVE SURGERY MARKET (2024) 291 FIGURE 41 MINIMALLY INVASIVE SURGERY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 294 FIGURE 42 MINIMALLY INVASIVE SURGERY MARKET: COMPANY FOOTPRINT 295 FIGURE 43 MINIMALLY INVASIVE SURGERY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 301 FIGURE 44 EV/EBITDA OF KEY VENDORS 303 FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 303 FIGURE 46 MINIMALLY INVASIVE SURGERY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 304 FIGURE 47 MEDTRONIC: COMPANY SNAPSHOT 308 FIGURE 48 JOHNSON & JOHNSON: COMPANY SNAPSHOT 316 FIGURE 49 STRYKER: COMPANY SNAPSHOT 321 FIGURE 50 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 326 FIGURE 51 ABBOTT: COMPANY SNAPSHOT 331 FIGURE 52 ZIMMER BIOMET: COMPANY SNAPSHOT 334 FIGURE 53 B. BRAUN SE: COMPANY SNAPSHOT 337 FIGURE 54 GLOBUS MEDICAL: COMPANY SNAPSHOT 340 FIGURE 55 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT 343 FIGURE 56 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 345 FIGURE 57 FUJIFILM CORPORATION: COMPANY SNAPSHOT 350 FIGURE 58 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 354 FIGURE 59 INTUITIVE SURGICAL OPERATIONS, INC.: COMPANY SNAPSHOT 359 FIGURE 60 GE HEALTHCARE: COMPANY SNAPSHOT 365